Exagen_Full_CMYK_Print.jpg
Exagen to Present at the Canaccord Genuity 40th Annual Growth Conference
30 juil. 2020 16h25 HE | Exagen Inc.
SAN DIEGO, July 30, 2020 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, today announced...
Exagen_Full_CMYK_Print.jpg
Exagen Inc. Reports Second Quarter 2020 Results
28 juil. 2020 07h00 HE | Exagen Inc.
Testing Experiencing Monthly Sequential ImprovementRecord Gross Margins of 63% SAN DIEGO, July 28, 2020 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming...
Exagen_Full_CMYK_Print.jpg
Exagen Inc. AVISE Testing Now Covered and In-Network with TRICARE East
27 juil. 2020 16h05 HE | Exagen Inc.
SAN DIEGO, July 27, 2020 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, today announced...
Exagen_Full_CMYK_Print.jpg
Exagen to Announce Second Quarter Financial Results on July 28, 2020
16 juil. 2020 10h45 HE | Exagen Inc.
SAN DIEGO, July 16, 2020 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, today announced...
Exagen_Full_CMYK_Print.jpg
Exagen and the Ohio State Innovation Foundation Announce Exclusive License Agreement and Research Collaboration for a Novel, Rule-In, Blood Test to Support the Diagnosis of Fibromyalgia
17 juin 2020 08h25 HE | Exagen Inc.
SAN DIEGO, June 17, 2020 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, today announced...
Exagen_Full_CMYK_Print.jpg
Exagen Inc. Announces Clinical Trial Conducted at Major Academic Center in Distinguishing Type 1 and Type 2 Lupus
03 juin 2020 08h25 HE | Exagen Inc.
SAN DIEGO, June 03, 2020 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, announced today...
Exagen_Full_CMYK_Print.jpg
Exagen to Present at the William Blair 40th Annual Growth Stock Conference
26 mai 2020 08h25 HE | Exagen Inc.
SAN DIEGO, May 26, 2020 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, today announced...
Exagen_Full_CMYK_Print.jpg
Exagen Inc. Reports First Quarter 2020 Results
11 mai 2020 16h05 HE | Exagen Inc.
SAN DIEGO, May 11, 2020 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, today reported...
Exagen_Full_CMYK_Print.jpg
Exagen to Announce First Quarter Financial Results on May 11, 2020
27 avr. 2020 08h25 HE | Exagen Inc.
SAN DIEGO, April 27, 2020 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from debilitating and chronic autoimmune...
Exagen_Full_CMYK_Print.jpg
Exagen Inc. Reports Fourth Quarter and Full Year 2019 Results
25 mars 2020 16h05 HE | Exagen, Inc.
SAN DIEGO, March 25, 2020 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from debilitating and chronic autoimmune...